This new
450-page report from Venture Planning Group contains 53 tables, and provides a
comprehensive analysis of the POC coagulation testing market, including trends,
dynamics, size, growth, regulatory requirements, technological trends,
competitive landscape, and emerging opportunities for instrument and consumable
suppliers. This report will help diagnostic product suppliers develop effective
business, R&D and marketing strategies for the global POC coagulation
market.
Rationale
The
growing economic pressures on hospitals, coupled with advances in diagnostic
technologies, intensifying competition among suppliers and physicians, and
changing consumer demands are shifting diagnostic testing from hospitals and
commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review
of nine POC market segments, including their dynamics, trends, structure, size,
growth and major suppliers.
- Five-year
test volume and reagent sales forecasts for coagulation procedures by market
segment:
- Physician
Offices/Group Practices
- Emergency
Rooms
- Operating/Recovery
Suites
- ICUs/CCUs
- Cancer
Clinics
- Ambulatory
Care Centers
- Surgery
Centers
- Nursing
Homes
- Birth
Centers
Sales
and Market Share Analysis
- Sales and market shares of major coagulation
reagent and instrument suppliers.
Current
and Emerging Products
- Analysis of coagulation procedures performed in
POC testing locations.
- Review of leading coagulation analyzers, both
currently marketed and those in development, including their operating
characteristics, features and selling prices.
Technology
Review
- Emerging technologies and their applications for
POC testing.
- Comprehensive listings of companies developing or
marketing coagulation testing technologies and products, by assay.
Inquire
for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=91083
Competitive
Assessments
- Assessments of major suppliers and emerging market
entrants, including their sales, product portfolios, marketing tactics, joint
ventures, and new products in R&D.
Strategic
Recommendations
- Specific opportunities for new coagulation
instruments and reagent systems with potentially significant market appeal
during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and
secondary sources of information, including review of the latest technical and
business publications, manufacturer product literature, industry analyst
reports, and Venture Planning Group’s proprietary data files.
Request
a Sample Copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=91083
Table
of Content
Introduction
Executive
Summary
Rationale
for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide
Market and Technology Overview
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time
Instrumentation:
Coagulation Analyzers Manufactured by:
Behnk Elektronik
Bio/Data
Cardiovascular Diagnostics
Diagnostica Stago
Helena Laboratories
Instrumentation Laboratory
ITC Hemochron
Roche
Siemens
Sysmex
Teco Medical Instruments
Trinity Biotech
Behnk Elektronik
Bio/Data
Cardiovascular Diagnostics
Diagnostica Stago
Helena Laboratories
Instrumentation Laboratory
ITC Hemochron
Roche
Siemens
Sysmex
Teco Medical Instruments
Trinity Biotech
Current
and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
Germany
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements,
Installed Base, Consumables Sales and Market Shares
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
Germany
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements,
Installed Base, Consumables Sales and Market Shares
Spain
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
Major
Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
Design
Criteria for Decentralized Testing Products
Alternative
Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential
Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company
ProfileA. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Abbott
ADI/America Diagnostica
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Biomerieux
Bio-Rad
Biosite/Inverness/Alere
Cephid
Chrono-Log
Corgenix
Decode
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio/Innogenetics
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
International Technidyne/Nexus DX
Kreatech
Kyowa Medex
Life Technologies
No comments:
Post a Comment
Note: only a member of this blog may post a comment.